A B C D E F G H I J K L M N O P Q R S T U V W X Y Z # |
PACKED CELLS (LEUKOREDUCED)
Test CodePCL
Patient Preparation
Patient must have a valid type and screen, if not product will be emergency release.
Instructions
The patient must have a red wristband for checking against component container label prior to administration. I.V. must be running and consent form must be signed. Many of the important clinical manifestations of transfusion reaction occur during the administration of the first 50-100 mL blood; therefore, the need for closest attention is during the early period of the transfusion. Temperature, pulse, and blood pressure must be taken and recorded before transfusion and then at 15 minutes after the transfusion is started and every hour during infusion.
Transport Container
Hand pickup or via tube system (MSH only)
Transport Temperature
Room Temperature
Specimen Stability
Blood <72 hours old for Packed Cells and within appropriate temperature range.
Setup Schedule
Daily, 24 hours
Clinical Significance
Use Leukoreduction of blood is an acceptable alternate means to minimize the risk of transfusion associated with CMV infection, reduces or eliminates transfusion complications such as non-hemolytic febrile transfusion reactions, alloimmunizations, and platelet refractoriness. Additional Information Leukocyte reduction is achieved by filtration: 1) soon after collection (prestorage) or 2) after varying periods of storage in the laboratory. Leukocyte reduction will decrease the cellular content and volume of blood according to characteristics of the filter system used. Leukocyte reduction filters variably remove other cellular elements in addition to white cells.
Performing Laboratory
Mount Sinai Hospital
Holy Cross Hospital